Efficacy and Tolerability of Antistax® in Male and Female Patients Suffering From Chronic Venous Insufficiency

NCT02191254 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

245

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Insufficiency

Interventions

DRUG: Antistax®
DRUG: Placebo

Sponsor

Boehringer Ingelheim